Summary of Significant Accounting Policies (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012	Sep. 30, 2013	Sep. 30, 2012	Dec. 31, 2012
Significant Accounting Policies [Line Items]
Receivable Balance	$ 7,176,071		$ 7,176,071		$ 5,373,023
Accounts receivable, allowance for doubtful accounts	1,159,756		1,159,756		991,990
Revenue from pharmaceutical clients	1,550,764	2,379,922	6,200,295	4,410,585
Bad debt expense			1,506,654	897,182
Amortization period of software development costs			5 years
Line of credit, expiration date			Mar. 07, 2015
Line of credit, fee for unused portion			0.25%	0.375%
Line of credit, maximum borrowing capacity	2,000,000		2,000,000
Line of credit, borrowing base percentage of pharmaceutical accounts receivable	80.00%		80.00%
Line of credit, interest above prime rate			1.00%
Line of credit, interest charged			5.00%
Line of credit, amount drawn	1,000,000		1,000,000		1,000,000
Required minimum bank balance	4,000,000		4,000,000
Advertising costs	10,924	655	14,247	13,626
Uninsured foreign cash balance	7,108		7,108
Federal Insurance Coverage Reverted					250,000
Maximum [Member]
Significant Accounting Policies [Line Items]
Amortization period of software development costs			5 years
Line of credit, minimum quick ratio			1.5
Minimum [Member]
Significant Accounting Policies [Line Items]
Amortization period of software development costs			4 years
Line of credit, minimum quick ratio			1.00
Letter of Credit [Member]
Significant Accounting Policies [Line Items]
Line of credit, maximum borrowing capacity	500,000		500,000
Cost of Goods, Total [Member] | Supplier Concentration Risk [Member]
Significant Accounting Policies [Line Items]
Concentration risk percentage	87.00%	71.00%	90.00%	70.00%
Clinical [Member]
Significant Accounting Policies [Line Items]
Receivable Balance	2,559,553		2,559,553		2,549,665
Payment period from the date of invoice			45 days
ResponseDX [Member]
Significant Accounting Policies [Line Items]
Accounts receivable, allowance for doubtful accounts	1,159,756		1,159,756		991,990
Bad debt expense	$ 688,205	$ 589,917	$ 1,506,655	$ 897,128